CYDECTIN TRICLAMOX 1 MG/ML + 50 MG/ML ORAL SOLUTION FOR SHEEP

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

现在购买

下载 产品特点 (SPC)
12-06-2017

有效成分:

MOXIDECTIN, TRICLABENDAZOLE

可用日期:

Zoetis Ireland Limited

ATC代码:

QP54AB52

INN(国际名称):

MOXIDECTIN, TRICLABENDAZOLE

剂量:

1/50

药物剂型:

Oral Solution

处方类型:

LM: Licensed Merchant as defined in relevant national legislation

治疗组:

Ovine

治疗领域:

moxidectin, combinations

疗效迹象:

Endectoparasiticides

授权状态:

Authorised

授权日期:

2013-12-09

产品特点

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for sheep.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
3 PHARMACEUTICAL FORM
Oral solution.
A clear yellow to brown liquid.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep.
ACTIVE SUBSTANCES
Moxidectin
1.0
mg
Triclabendazole
50.0 mg
EXCIPIENTS
Benzyl alcohol (E1519)
40.0 mg
Butylhydroxytoluene (E321)
1.0
mg
For the full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_4_
_/_
_0_
_5_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_5_
_0_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of mixed nematode and fluke infections, caused by
moxidectin and triclabendazole sensitive strains
of:
The product has a persistent efficacy and protects sheep against
infection or re-infection with the following parasites for
the period indicated:
Clinical trials, after experimental and natural infection, have shown
that the product is effective against certain
benzimidazole resistant strains of:
_Haemonchus contortus_
_Teladorsagia circumcincta_
_Trichostrongylus colubriformis_
_Cooperia curticei_
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance(s) or
to any of
the excipient(s).
Parasite
ADULT STAGE
L4
INHIBITED STAGES
NEMATODES
GASTRO-INTESTINAL NEMATODES:
_Haemonchus contortus_
_Teladorsagia
                                
                                阅读完整的文件